Philadelphia Chromosome Positive Recruiting Phase 1 Trials for Cytarabine (DB00987)

Also known as: Philadelphia chromosome positive

IndicationStatusPhase
DBCOND0046287 (Philadelphia Chromosome Positive)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03519984EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute LeukemiaTreatment